ICON plc

NASDAQ: ICLRHealthcare / Medical Laboratories & Research / Ireland
153.41-2.90-1.86%Vol 131 0201Y Perf 6.05%
Aug 23rd, 2019 16:00
BID153.41 ASK153.62
Open156.36 Previous Close156.31
Pre-Market- After-Trading153.41
 - -%  - -%
Target Price
165.89 
Analyst Rating
Moderate Buy 1.67
Potencial %
8.14 
Finscreener Ranking
★★★+     51.51
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★★+     55.38
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★★+     63.48
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)8 280 
Earnings Rating
Buy
Price Range Ratio 52wk %
75.08 
Earnings Date
24th Jul 2019

Today's Price Range

153.06157.58

52wk Range

118.10165.13

5 Year PE Ratio Range

15.6036.20

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
-2.39%
1 Month
-1.92%
3 Months
8.88%
6 Months
5.66%
1 Year
6.05%
3 Years
104.49%
5 Years
198.81%
10 Years
558.13%

Name / TickerPriceChg.Chg.%
ICLR153.41-2.9000-1.86
AAPL202.64-9.8200-4.62
GOOG1 151.29-38.2400-3.21
MSFT133.39-4.3900-3.19
XOM67.49-2.0800-2.99
WFC44.42-1.2000-2.63
JNJ127.73-3.5400-2.70
FB177.75-4.2900-2.36
GE7.97-0.2200-2.69
JPM106.02-2.7000-2.48
Earnings HistoryEstimateReportedSurprise %
Q02 20191.681.690.60
Q01 20191.601.631.88
Q04 20181.601.621.25
Q03 20181.541.540.00
Q02 20181.481.512.03
Q01 20181.411.420.71
Q04 20171.411.431.42
Q03 20171.311.353.05
Earnings Per EndEstimateRevision %Trend
9/2019 QR1.730.00-
12/2019 QR1.820.00-
12/2019 FY6.870.00-
12/2020 FY7.660.00-
Next Report Date-
Estimated EPS Next Report1.68
Estimates Count8
EPS Growth Next 5 Years %10.60
Volume Overview
Volume131 020
Shares Outstanding (in ths.)53 971
Trades Count603
Dollar Volume12 996 690
Avg. Volume275 520
Avg. Weekly Volume157 326
Avg. Monthly Volume209 436
Avg. Quarterly Volume236 838
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (66.67 %)
7 (63.64 %)
8 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
4 (33.33 %)
3 (27.27 %)
3 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
1 (9.09 %)
1 (8.33 %)
RatingModerate Buy
1.67
Moderate Buy
1.91
Moderate Buy
1.83

ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

CEO: Steven Cutler

Teplephone: +353 12912000

Address: South County Business Park, Dublin 18, , IRL

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

40%60%

Bearish Bullish

57%43%

Bearish Bullish

53%47%

News